Laboratory-based biomarkers to improve causality assessment in drug-induced liver injury [0.03%]
实验室生物标志物在药物性肝损伤因果关系判定中的应用
Daniel J Antoine
Daniel J Antoine
Paul H Hayashi
Paul H Hayashi
Kent Benner,Ken Flora,Pippa Newell
Kent Benner
Changes in united network for organ sharing policy for simultaneous liver-kidney allocation [0.03%]
联合器官共享网络同时肝肾移植分配政策变化
Jonathan Merola,Richard N Formica,David C Mulligan
Jonathan Merola
Thrombosis and coagulopathy in the liver transplant candidate and recipient [0.03%]
肝移植供者和受者的血栓形成与凝血功能障碍
R Todd Stravitz
R Todd Stravitz
Elastography to assess the stage of liver fibrosis in children: Concepts, opportunities, and challenges [0.03%]
弹性图评估儿童肝纤维化分期:概念、机遇与挑战
Suraj D Serai,Andrew T Trout,Claude B Sirlin
Suraj D Serai
Susanne N Weber,Frank Lammert
Susanne N Weber
The new treatments for hepatitis C virus: An advanced practice provider's perspective [0.03%]
丙型肝炎病毒的新疗法——从业者观点
Lisa Cervantes
Lisa Cervantes
Fasiha Kanwal
Fasiha Kanwal